Close

Drug Research

Role of AI In Transforming Drug Discovery And Development

Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies, pharmaceutical companies can streamline processes, reduce costs, and enhance the accuracy and speed of drug...

AI-Driven Route Scouting Revolutionizes Drug Development

Lonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug (IND) submissions. By integrating artificial intelligence (AI) into their processes, Lonza has been able to significantly reduce the time...

Innovations In Biologic Drug Delivery Beyond Injections

Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such as monoclonal antibodies (mAbs) and some vaccines are largely administered via injection or by infusion. These methods can often...

Pharma Future : Innovations In Drug Delivery Nanoparticles

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of unfulfilled requirements, and the increasing significance of technology like pharmacogenomics, digital therapies, and artificial intelligence are what propel activity....

New Nickel Complex Revolutionizes Pharmaceutical Synthesis

The creation of a tool that can enable organic chemical processes that were not possible before has given the pharmaceutical business new ways to make effective drugs more quickly. In the past, most drugs were put together using alkyl building...

Speeding Up Toxicology Materials For Faster Drug Development

Quick delivery of toxicological materials According to Alejandro Fernandez Martell and James Berrie from Lonza, a bottleneck has developed in the supply of toxicological data to support INDs for novel therapies and, therefore, delivery of FIH studies, as a result...

ArisGlobal Extends Collaboration with Sitero for Drug Development Technology Platform

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, and Sitero LLC, a next-generation clinical trial solutions provider, today announced an expansion of their strategic partnership. This collaboration integrates Sitero's unified eClinical technology platform...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read